Qingxi Wang

Qingxi Wang is currently the Chairman & Chief Executive Officer at Conjupro Biotherapeutics, Inc. and an Executive Director at CSPC Pharmaceutical Group Ltd.
Previously, he worked as a Director of Operations & Business Development at Merck & Co., Inc. Dr. Wang holds a Master's in Business Administration from Temple University, a graduate and doctorate degree from the University of Connecticut, and undergraduate and graduate degrees from Nankai University.